{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:00:38Z","timestamp":1787868038227,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T00:00:00Z","timestamp":1421798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["currenttherapeuticres.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.curtheres.2015.01.001","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T20:31:24Z","timestamp":1422477084000},"page":"46-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study"],"prefix":"10.1016","volume":"77","author":[{"given":"Matti","family":"Kivikko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Kuoppam\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Soinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Sundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Pohjanjousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Ellmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto O.","family":"Roine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"159","key":"10.1016\/j.curtheres.2015.01.001_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","article-title":"Levosimendan: Molecular mechanisms and clinical implications. Consensus of experts on the mechanisms of action of levosimendan","volume":"23","author":"Papp","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.curtheres.2015.01.001_bib2","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0735-1097(00)00961-X","article-title":"Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure","volume":"36","author":"Nieminen","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.curtheres.2015.01.001_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.curtheres.2015.01.001_bib4","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/01.CIR.102.18.2222","article-title":"Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure","volume":"102","author":"Slawsky","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.curtheres.2015.01.001_bib5","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.curtheres.2015.01.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2015.01.037","article-title":"Levosimendan alone and in combination with valsartan prevents stroke in Dahl salt-sensitive rats","author":"Levijoki","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.curtheres.2015.01.001_bib7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2377-13-106","article-title":"Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model","volume":"13","author":"Hein","year":"2013","journal-title":"BMC Neurol"},{"key":"10.1016\/j.curtheres.2015.01.001_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00000539-200001000-00003","article-title":"Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of KATP channels","volume":"90","author":"Kersten","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1016\/j.curtheres.2015.01.001_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.atherosclerosis.2007.04.023","article-title":"Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure","volume":"197","author":"Parissis","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.curtheres.2015.01.001_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.20999","article-title":"Levosimendan has anti-inhibitory effect on platelet function","volume":"83","author":"Kaptan","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.curtheres.2015.01.001_bib11","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ejheart.2008.09.006","article-title":"Oral levosimendan in patients with severe chronic heart failure --the PERSIST study","volume":"10","author":"Nieminen","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.curtheres.2015.01.001_bib12","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1001\/jama.283.16.2122","article-title":"Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis","volume":"283","author":"Silvestrini","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.curtheres.2015.01.001_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ejps.2007.08.003","article-title":"Pharmacokinetics and excretion balance of OR-1896, a pharmacologically active metabolite of levosimendan, in healthy men","volume":"32","author":"Puttonen","year":"2007","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.curtheres.2015.01.001_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1177\/0091270004268319","article-title":"Pharmacodynamics and pharmacokinetics of oral levosimendan and its metabolites in patients with severe congestive heart failure: a dosing interval study","volume":"44","author":"P\u00f5der","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.curtheres.2015.01.001_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000314955","article-title":"Acute Effects of Levosimendan on Cerebral and Systemic Perfusion and Oxygenation in Newborns: An Observational Study","volume":"99","author":"Bravo MdC","year":"2011","journal-title":"Neonatology"},{"key":"10.1016\/j.curtheres.2015.01.001_bib16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3109\/02699051003789260","article-title":"Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: An experimental study","volume":"24","author":"Cengiz","year":"2010","journal-title":"Brain Injury"},{"key":"10.1016\/j.curtheres.2015.01.001_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/2047-783X-18-53","article-title":"Systematic study of cilostazol on secondary stroke prevention: a meta-analysis","volume":"18","author":"Qian","year":"2013","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.curtheres.2015.01.001_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ejheart.2008.07.002","article-title":"Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: A meta-analysis","volume":"10","author":"de Sousa","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.curtheres.2015.01.001_bib19","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/oxfordjournals.eurheartj.a015174","article-title":"Survival and incidence of myocardial infarction in men with ambulatory ECG-detected frequent and complex ventricular arrhythmias. 10 year follow-up of the \u2018Men born 1914\u2019 study in Malmo, Sweden","volume":"18","author":"Hedblad","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.curtheres.2015.01.001_bib20","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/STROKEAHA.109.567800","article-title":"Premature ventricular complexes and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"41","author":"Agarwal","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.curtheres.2015.01.001_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00005344-200004000-00021","article-title":"Electrophysiologic effects of a calcium sensitizer inotrope levosimendan administered intravenously in patients with normal cardiac function","volume":"35","author":"Toivonen","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.curtheres.2015.01.001_bib22","first-page":"107","article-title":"Clinical utility of B-type natriuretic peptide for estimating left ventricular filling pressures in unselected elderly patients undergoing diagnostic coronary angiography","volume":"22","author":"Stolker","year":"2010","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.curtheres.2015.01.001_bib23","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1161\/01.STR.0000227121.34717.40","article-title":"Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population","volume":"37","author":"Hays","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.curtheres.2015.01.001_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5414\/CPP40465","article-title":"Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure","volume":"40","author":"Kivikko","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2015.01.001_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejps.2004.07.005","article-title":"Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators","volume":"23","author":"Antila","year":"2004","journal-title":"Eur J Pharm Sci"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X15000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X15000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T19:51:12Z","timestamp":1537905072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X15000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":25,"alternative-id":["S0011393X15000028"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2015.01.001","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2015.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}